A new report details the potential for floating offshore wind to lower energy costs and enhance the resilience of the nation’s western grid.

PNNL’s year in review includes highlights ranging from advancing soil science to understanding Earth systems, expanding electricity transmission, detecting fentanyl, and applying artificial intelligence to aid scientific discovery.

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.

The National Transmission Planning Study presents several transmission expansion scenarios that would reliably support the growing demand for energy across the nation.

A cross-institutional team of scientists developed PeakQC, a new software tool for automated quality control of mass spectrometry data.

New transmission lines and renewable energy projects would bring economic and climate change benefits to the Western United States’s electricity grid.

Ljiljana Paša-Tolić, a PNNL fellow, is the recipient of the 2024 International Mass Spectrometry Foundation’s Jochen Franzen Award. 

Scientists have developed a way to detect tiny amounts of hard-to-detect explosives more than eight feet away.

A team of researchers from Pacific Northwest National Laboratory and the Environmental Molecular Sciences Laboratory developed a new and flexible software tool called “Advanced Spectra PCA Toolbox.”

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Three PNNL-affiliated researchers have been named fellows of the American Association for the Advancement of Science, the world’s largest multidisciplinary scientific society.

Scott Baker, the Functional and Systems Biology Group leader at PNNL, has been named to the American Institute for Medical and Biological Engineering's Class of 2024 Fellows.

Department of Energy presented six teams from PNNL with the Secretary's Honor Award.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

PNNL’s software tool brings together artificial intelligence and satellite imagery to help responders assess damage and take action.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Recovery Simulator and Analysis tool further strengthens PNNL’s short-term resilience planning efforts for Puerto Rico.